1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Alzheimer’s disease Diagnostic Market, by Type
5.1 Introduction
5.1.1 Early-onset Alzheimer's
5.1.2 Late-onset Alzheimer's
5.1.3 Familial Alzheimer's disease
5.1.4 Others
6 Global Alzheimer’s disease Diagnostic Market, by Diagnostic tests
6.1 Introduction
6.1.1 Genetic testing
6.1.2 Neurological exam
6.1.3 Mini-mental state exam (MMSE)
6.1.4 Brain imaging
6.1.5 Others
7 Global Alzheimer’s disease Diagnostic Market, by End Users
7.1 Introduction
7.1.1 Clinics
7.1.3 Hospitals
7.1.4 Diagnostic Centers
7.1.5 Others
8 Global Alzheimer’s Disease Diagnostic Market, by Regions
8.1 Introduction
8.1.1 Americas
8.1.1.1 North America
8.1.1.2 South America
8.1.2 Europe
8.1.2.1 Germany
8.1.2.2 France
8.1.2.3 UK
8.1.2.4 Italy
8.1.2.5 Spain
8.1.2.6 Rest of Europe
8.1.3 Asia Pacific
8.1.3.1 Japan
8.1.3.2 China
8.1.3.3 India
8.1.3.4 Republic of Korea
8.1.3.5 Rest of Asia Pacific
8.1.4 Middle East & Africa
9 Company Landscape
9.1 Introduction
9.1.1 Mergers Acquisitions
9.1.2 Collaborations
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 Accera, Inc.
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financials
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Alector LLC
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financials
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Cognition Therapeutics Inc.
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financials
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 Eli Lilly and Company
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financials
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 Neuro-Bio Ltd
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financials
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 TauRx
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financials
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Treventis Corporation
10.7.1 Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Others
11 Appendix
List of Tables
TABLE 1 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, 2020-2027 (USD MILLION)
TABLE 2 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION, 2020-2027 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL ORTHOPEDIC TRAUMA DEVICE SMARKET, BY TYPE
FIGURE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE
FIGURE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS
FIGURE 6 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION
FIGURE 7 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
